atracurium besylate injection, USP How Supplied/Storage and Handling
HOW SUPPLIED
Atracurium Besylate Injection USP, each mL containing 10 mg atracurium besylate, is supplied as follows:
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1109-01 Carton of 10 Single dose Vials | 50 mg/5 mL (10 mg/mL) |
| NDC 0409-1105-02 *Carton of 10 Multiple dose Vials | 100 mg/10 mL (10 mg/mL) |
Atracurium Besylate Injection should be refrigerated at 2°C to 8°C (36°F to 46°F) to preserve potency. DO NOT FREEZE. Protect from light. Keep vials in carton until time of use.
Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if rerefrigerated.
Manufactured by:
Gland Pharma Limited;
Hyderabad 500043, India
Manufactured for:
Hospira, Inc.
Lake Forest, IL 60045 USA
LAB-1214-4.0
Revised: 07/2021
Find atracurium besylate injection, USPÂ medical information:
Find atracurium besylate injection, USP medical information:
atracurium besylate injection, USP Quick Finder
Health Professional Information
How Supplied/Storage and Handling
HOW SUPPLIED
Atracurium Besylate Injection USP, each mL containing 10 mg atracurium besylate, is supplied as follows:
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1109-01 Carton of 10 Single dose Vials | 50 mg/5 mL (10 mg/mL) |
| NDC 0409-1105-02 *Carton of 10 Multiple dose Vials | 100 mg/10 mL (10 mg/mL) |
Atracurium Besylate Injection should be refrigerated at 2°C to 8°C (36°F to 46°F) to preserve potency. DO NOT FREEZE. Protect from light. Keep vials in carton until time of use.
Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if rerefrigerated.
Manufactured by:
Gland Pharma Limited;
Hyderabad 500043, India
Manufactured for:
Hospira, Inc.
Lake Forest, IL 60045 USA
LAB-1214-4.0
Revised: 07/2021
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.